Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - anti-TNF therapy
THU0184 Predictive Marker for the Long-Term Discontinuation of Infliximab in Rheumatoid Arthritis with Clinical Remission
Compose a Response to This Article
Other responses
No responses have been published for this article.